Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)
Phase 2
- Conditions
- Tuberculosis Identification.
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 90
- Registration Number
- NCT01798121
Equivalence Study of Specificity of PPD
Phase 2
- Conditions
- Tuberculosis Infection
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 152
- Registration Number
- NCT01798095
- Locations
- 🇺🇸
The University of Texas Health Science Center at Tyler, Tyler, Texas, United States
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Phase 2
- Conditions
- Tuberculosis Infection
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2012-09-21
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 168
- Registration Number
- NCT01689831
- Locations
- 🇺🇸
The University of Texas Health Science Center at Tyler, Tyler, Texas, United States
News
No news found